| DTI measurements for Alzheimer’s classification T Maggipinto, R Bellotti, N Amoroso, D Diacono, G Donvito, E Lella, ... Physics in Medicine & Biology 62 (6), 2361, 2017 | 77 | 2017 |
| Genetic study of multimodal imaging Alzheimer’s disease progression score implicates novel loci MA Scelsi, RR Khan, M Lorenzi, L Christopher, MD Greicius, JM Schott, ... Brain, 2018 | 69 | 2018 |
| A comprehensive analysis of methods for assessing polygenic burden on Alzheimer’s disease pathology and risk beyond APOE A Altmann, MA Scelsi, M Shoai, E de Silva, LM Aksman, DM Cash, ... Brain communications 2 (1), fcz047, 2020 | 55 | 2020 |
| Modeling longitudinal imaging biomarkers with parametric Bayesian multi‐task learning LM Aksman, MA Scelsi, AF Marquand, DC Alexander, S Ourselin, ... Human brain mapping 40 (13), 3982-4000, 2019 | 31 | 2019 |
| Hippocampal subfield volumetry: Differential pattern of atrophy in different forms of genetic frontotemporal dementia M Bocchetta, JE Iglesias, MA Scelsi, DM Cash, MJ Cardoso, M Modat, ... Journal of Alzheimer's Disease 64 (2), 497-504, 2018 | 29 | 2018 |
| Segmentation of medial temporal subregions reveals early right-sided involvement in semantic variant PPA M Bocchetta, JE Iglesias, LL Russell, CV Greaves, CR Marshall, ... Alzheimer's research & therapy 11 (1), 1-9, 2019 | 23 | 2019 |
| KL∗ VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE∗ 4 carriers ME Belloy, SJ Eger, Y Le Guen, V Napolioni, KD Deters, HS Yang, ... Neurobiology of aging 101, 123-129, 2021 | 13 | 2021 |
| Genome wide association study of incomplete hippocampal inversion in adolescents C Cury, MA Scelsi, R Toro, V Frouin, E Artiges, A Grigis, A Heinz, ... PLoS One 15 (1), e0227355, 2020 | 10 | 2020 |
| Comparing ARIA‐E severity scales and effects of treatment management thresholds G Klein, MA Scelsi, J Barakos, JB Fiebach, L Bracoud, J Suhy, P Delmar, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 14 (1 …, 2022 | 9 | 2022 |
| Establishing online mentorship for early career researchers: Lessons from the Organization for Human Brain Mapping International Mentoring Programme N Bielczyk, M Veldsman, A Ando, C Caldinelli, MM Makary, A Nikolaidis, ... European Journal of Neuroscience 49 (9), 1069-1076, 2019 | 7 | 2019 |
| A data-driven study of Alzheimer's disease related amyloid and tau pathology progression LM Aksman, NP Oxtoby, MA Scelsi, PA Wijeratne, AL Young, IL Alves, ... Brain 146 (12), 4935-4948, 2023 | 5 | 2023 |
| Tau-first subtype of Alzheimer's disease consistently identified across in vivo and post mortem studies LM Aksman, NP Oxtoby, MA Scelsi, PA Wijeratne, AL Young, ... bioRxiv, 2020.12. 18.418004, 2020 | 5 | 2020 |
| [IC‐P‐047]: THE ROLE OF HIPPOCAMPAL SUBFIELDS IN THE ATROPHY PROCESS IN ALZHEIMER's DISEASE: AN IN‐VIVO STUDY OF THE ADNI COHORT MA Scelsi, E Iglesias, JM Schott, S Ourselin, A Altmann, ... Alzheimer's & Dementia 13 (7S_Part_1), P40-P41, 2017 | 5* | 2017 |
| Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial O Wagemann, H Liu, G Wang, X Shi, T Bittner, MA Scelsi, MR Farlow, ... JAMA neurology, 2024 | 4 | 2024 |
| Glucose hypometabolism in the auditory pathway in age related hearing loss in the ADNI cohort FNZ Abidin, MA Scelsi, SJ Dawson, A Altmann, ... NeuroImage: Clinical 32, 102823, 2021 | 4 | 2021 |
| Validation of 3‐and 5‐point severity scales to assess ARIA‐E L Bracoud, G Klein, M Lyons, MA Scelsi, J Wojtowicz, S Bullain, D Purcell, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 15 (4 …, 2023 | 3 | 2023 |
| Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer’s disease RE Green, J Lord, MA Scelsi, J Xu, A Wong, S Naomi-James, A Handy, ... Alzheimer's research & therapy 15 (1), 38, 2023 | 3 | 2023 |
| Network propagation of rare variants in Alzheimer’s disease reveals tissue-specific hub genes and communities MA Scelsi, V Napolioni, MD Greicius, A Altmann, ... PLoS Computational Biology 17 (1), e1008517, 2021 | 3* | 2021 |
| O3‐10‐04: GENOMEWIDE ASSOCIATION STUDY OF DATA‐DRIVEN ALZHEIMER'S DISEASE SUBTYPES AL Young, MA Scelsi, RV Marinescu, JM Schott, S Ourselin, ... Alzheimer's & Dementia 14 (7S_Part_19), P1042-P1043, 2018 | 3 | 2018 |
| Gantenerumab treatment increases plasma beta‐amyloid (1–42) and decreases plasma pTau T Bittner, MA Scelsi, G Kollmorgen, A Jethwa, GA Kerchner, P Fontoura, ... Alzheimer's & Dementia 18, e065684, 2022 | 2 | 2022 |
Andre AltmannUCL在 ucl.ac.uk 的电子邮件经过验证
